360
Views
20
CrossRef citations to date
0
Altmetric
Theme: Mood Disorders - Review

Is there a clinical prodrome of bipolar disorder? A review of the evidence

&
Pages 89-98 | Published online: 09 Jan 2014

References

  • WHO. ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. WHO, Geneva, Switzerland (1992).
  • Taylor M, Bressan RA, Pan Neto P, Brietzke E. Early intervention for bipolar disorder: current imperatives, future directions. Rev. Bras. Psiquiatr. 33(Suppl. 2), s197–s212 (2011).
  • Elanjithara T, Frangou S, McGuire P. Treatment of the early stages of bipolar disorder. Adv. Psych. Treat. 17, 283–291 (2011).
  • Homish GG, Marshall D, Dubovsky SL, Leonard K. Predictors of later bipolar disorder in patients with subthreshold symptoms. J. Affec. Disord. 144(1–2), 129–133 (2012).
  • Merikangas KR, Jin R, He JP et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch. Gen. Psychiatry 68(3), 241–251 (2011).
  • Osby U, Brandt L, Correia N, Ekbom A, Sparén P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch. Gen. Psychiatry 58(9), 844–850 (2001).
  • Fajutrao L, Locklear J, Priaulx J, Heyes A. A systematic review of the evidence of the burden of bipolar disorder in Europe. Clin. Pract. Epidemiol. Ment. Health 5, 3 (2009).
  • Smith DJ, Ghaemi N. Is underdiagnosis the main pitfall when diagnosing bipolar disorder? Yes. BMJ 340, c854 (2010).
  • Cooper JE, Kendall R, Gurland BJ, Sartorius N, Farkas T. Psychiatric Diagnosis in New York and London. Oxford University Press, Oxford, UK (1972).
  • Pope HG Jr, Lipinski JF Jr. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of ‘schizophrenic’ symptoms in the light of current research. Arch. Gen. Psychiatry 35(7), 811–828 (1978).
  • Howes OD, Falkenberg I. Early detection and intervention in bipolar affective disorder: targeting the development of the disorder. Curr. Psychiatry Rep. 13(6), 493–499 (2011).
  • Berk M, Dodd S, Callaly P et al. History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. J. Affect. Disord. 103(1–3), 181–186 (2007).
  • Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J. Clin. Psychiatry 64(2), 161–174 (2003).
  • Mitchell PB, Goodwin GM, Johnson GF, Hirschfeld RM. Diagnostic guidelines for bipolar depression: a probabilistic approach. Bipolar Disord. 10(1 Pt 2), 144–152 (2008).
  • Duffy A, Alda M, Hajek T, Grof P. Early course of bipolar disorder in high-risk offspring: prospective study. Br. J. Psychiatry 195(5), 457–458 (2009).
  • Angst J. The bipolar spectrum. Br. J. Psychiatry 190, 189–191 (2007).
  • Franchini L, Zanardi R, Smeraldi E, Gasperini M. Early onset of lithium prophylaxis as a predictor of good long-term outcome. Eur. Arch. Psychiatry Clin. Neurosci. 249(5), 227–230 (1999).
  • Baldessarini RJ, Tondo L, Hennen J. Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. Bipolar Disord. 5(3), 169–179 (2003).
  • Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am. J. Psychiatry 156(8), 1264–1266 (1999).
  • Berk M, Brnabic A, Dodd S et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 13(1), 87–98 (2011).
  • Brietzke E, Mansur RB, Soczynska JK, Kapczinski F, Bressan RA, McIntyre RS. Towards a multifactorial approach for prediction of bipolar disorder in at risk populations. J. Affect. Disord. 140(1), 82–91 (2012).
  • Gazalle FK, Andreazza AC, Ceresér KM, Hallal PC, Santin A, Kapczinski F. Clinical impact of late diagnose of bipolar disorder. J. Affect. Disord. 86(2–3), 313–316 (2005).
  • Kapczinski F, Dias VV, Kauer-Sant’Anna M et al. The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 33(8), 1366–1371 (2009).
  • Moore PB, Shepherd DJ, Eccleston D et al. Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br. J. Psychiatry 178, 172–176 (2001).
  • Silverstone T, McPherson H, Li Q, Doyle T. Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. Bipolar Disord. 5(1), 53–57 (2003).
  • Soares JC, Kochunov P, Monkul ES et al. Structural brain changes in bipolar disorder using deformation field morphometry. Neuroreport 16(6), 541–544 (2005).
  • Moorhead TW, McKirdy J, Sussmann JE et al. Progressive gray matter loss in patients with bipolar disorder. Biol. Psychiatry 62(8), 894–900 (2007).
  • Blumberg HP, Krystal JH, Bansal R et al. Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol. Psychiatry 59(7), 611–618 (2006).
  • Strakowski SM, Wilson DR, Tohen M, Woods BT, Douglass AW, Stoll AL. Structural brain abnormalities in first-episode mania. Biol. Psychiatry 33(8–9), 602–609 (2003).
  • Tsai SY, Chung KH, Wu JY, Kuo CJ, Lee HC, Huang SH. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J. Affect. Disord. 136(1–2), 110–116 (2012).
  • Caggiula M, Batocchi AP, Frisullo G et al. Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis. Scand. J. Immunol. 62(2), 176–182 (2005).
  • Laske C, Stransky E, Leyhe T et al. Stage-dependent BDNF serum concentrations in Alzheimer’s disease. J. Neural Transm. 113(9), 1217–1224 (2006).
  • Martínez-Arán A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am. J. Psychiatry 161(2), 262–270 (2004).
  • Skjelstad DV, Malt UF, Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J. Affect. Disord. 126(1–2), 1–13 (2010).
  • Ritter PS, Marx C, Bauer M, Leopold K, Lepold K, Pfennig A. The role of disturbed sleep in the early recognition of bipolar disorder: a systematic review. Bipolar Disord. 13(3), 227–237 (2011).
  • Angst J, Sellaro R, Stassen HH, Gamma A. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J. Affect. Disord. 84(2–3), 149–157 (2005).
  • Angst J, Azorin J, Bowden C et al.; BRIDGE Study Group. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode, the BRIDGE study. Arch. Gen. Psychiatry 68(8), 791–798 (2011).
  • Forty L, Smith D, Jones L et al. Clinical differences between bipolar and unipolar depression. Br. J. Psychiatry 192(5), 388–389 (2008).
  • National Institute for Health and Clinical Excellence. The management of bipolar disorder in adults, children and adolescents, in primary and secondary care. Clinical Guideline 38. NICE (2006).
  • Taylor Tavares JV, Clark L, Cannon DM, Erickson K, Drevets WC, Sahakian BJ. Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression. Biol. Psychiatry 62(8), 917–924 (2007).
  • Konarski JZ, McIntyre RS, Kennedy SH, Rafi-Tari S, Soczynska JK, Ketter TA. Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord. 10(1), 1–37 (2008).
  • Hajek T, Kopecek M, Höschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J. Psychiatry Neurosci. 37(5), 333–343 (2012).
  • Howes OD, Lim S, Theologos G, Yung AR, Goodwin GM, McGuire P. A comprehensive review and model of putative prodromal features of bipolar affective disorder. Psychol. Med. 2010, 1–11 (2010).
  • Correll CU, Penzner JB, Frederickson AM et al. Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome. Schizophr. Bull. 33(3), 703–714 (2007).
  • Conus P, Ward J, Lucas N et al. Characterisation of the prodrome to a first episode of psychotic mania: results of a retrospective study. J. Affect. Disord. 124(3), 341–345 (2010).
  • Lichtenstein P, Yip H, Bjork C. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373, 234–239 (2009).
  • Forty L, Smith D, Jones L et al. Identifying hypomanic features in major depressive disorder using the hypomania checklist (HCL-32). J. Affect. Disord. 114(1–3), 68–73 (2009).
  • Perugi G, Fornaro M, Maremmani I et al. Discriminative Hypomania Checklist-32 factors in unipolar and bipolar major depressive patients. Psychopathology 45(6), 390–398 (2012).
  • Allen R, Smith D. Screening for bipolar disorder: strengths and limitations of currently available instruments. Prim. Care Community Psychiatr. 13(2), 47–51 (2008).
  • Leopold K, Ritter P, Correll CU et al. Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool. J. Affect. Disord. 136(3), 1000–1010 (2012).
  • Bechdolf A, Ratheesh A, Wood SJ et al. Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder. Curr. Pharm. Des. 18(4), 358–375 (2012).
  • Bechdolf A, Nelson B, Cotton SM et al. A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults. J. Affect. Disord. 127(1–3), 316–320 (2010).
  • Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am. J. Psychiatry 152(8), 1130–1138 (1995).
  • Leverich GS, Altshuler LL, Frye MA et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am. J. Psychiatry 163(2), 232–239 (2006).
  • Goodwin GM; Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J. Psychopharmacol. (Oxford) 23(4), 346–388 (2009).
  • Berk M, Conus P, Lucas N et al. Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord. 9(7), 671–678 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.